Literature DB >> 7506150

A comparison of nimesulide vs paracetamol in the treatment of pyrexia in the elderly.

E Cunietti1, M Monti, A Viganò, E D'Aprile, A Saligari, E Scafuro, I Scaricabarozzi.   

Abstract

The efficacy and safety of rectally administered nimesulide 200mg and paracetamol 500mg were assessed in a double-blind study. The study was conducted in 39 elderly inpatients with infections of the upper or lower respiratory tract associated with fever; 18 patients received nimesulide and 21 received paracetamol. Both treatments were given for 2 consecutive days and provided adequate therapy for pyrexia, with significant reductions in body temperature being observed. Both drugs were well tolerated. Only 1 patient in the nimesulide-treated group could not complete the study because cutaneous erythema occurred with itching; this resolved spontaneously upon treatment withdrawal. It is concluded that nimesulide is as active and safe as paracetamol for the treatment of pyrexia in the elderly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506150     DOI: 10.2165/00003495-199300461-00026

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  4 in total

1.  1983 Henderson Award Lecture. Thermal homeostasis in old age.

Authors:  K J Collins; A N Exton-Smith
Journal:  J Am Geriatr Soc       Date:  1983-09       Impact factor: 5.562

Review 2.  Fever and aging.

Authors:  D C Norman; D Grahn; T T Yoshikawa
Journal:  J Am Geriatr Soc       Date:  1985-12       Impact factor: 5.562

3.  A sulphonamido-indanone derivative CGP 28237 (ZK 34228), a novel non-steroidal anti-inflammatory agent without gastro-intestinal ulcerogenicity in rats.

Authors:  I Böttcher; A Schweizer; M Glatt; H Werner
Journal:  Drugs Exp Clin Res       Date:  1987

4.  Antipyretic activity of nimesulide suppositories: double blind versus diclofenac and placebo.

Authors:  M Reiner; S Cereghetti; M Haeusermann; T Monti
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1985-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.